Klinikum der Universität München

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany (2020) Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. Journal article BAGLS, a multihospital Benchmark for Automatic Glottis Segmentation (2020) Gómez P, Kist A, Schlegel P, Berry DA, Chhetri DK, Dürr S, Echternach M, et al. Journal article Imaging characteristics of intravascular spherical contrast agents for grating-based x-ray dark-field imaging – effects of concentrations, spherical sizes and applied voltage (2020) Notohamiprodjo S, Treitl KM, Hauke C, Sutter SM, Auweter S, Pfeiffer F, Reiser MF, Hellbach K Journal article IKKA-Score zur Vereinheitlichung der Beurteilung des individuellen Risikos durch SARS-CoV-2 (2020) Wolfschmidt A, Ochmann U, Nowak D, Drexler H Journal article Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional Study (2020) Jakob L, Steeb T, Fiocco Z, Pumnea T, Jakob SN, Wessely A, Rothenberger CC, et al. Journal article Treatment landscape and prognosis after treatment with trastuzumab emtansine (2020) Laakmann E, Emons J, Taran FA, Janni W, Uhrig S, Overkamp F, Kolberg HC, et al. Journal article S2k-Leitlinie: Management der Großgefäßvaskulitiden (2020) Schirmer JH, Aries PM, Balzer K, Berlit P, Bley TA, Buttgereit F, Czihal M, et al. Journal article, Review article S2k-Leitlinie (Kurzfassung): Management der Großgefäßvaskulitiden (2020) Schirmer JH, Aries PM, Balzer K, Berlit P, Bley TA, Buttgereit F, Czihal M, et al. Journal article, Review article Progression-free survival and overall survival in patients with advanced her2-positive breast cancer treated with trastuzumab emtansine (T-dm1) after previous treatment with pertuzumab (2020) Michel LL, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, Häberle L, et al. Journal article Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer (2020) Hecht M, Hahn D, Wolber P, Hautmann MG, Reichert D, Weniger S, Belka C, et al. Journal article